YU170475A - Process for preparing galenic formulations - Google Patents

Process for preparing galenic formulations

Info

Publication number
YU170475A
YU170475A YU01704/75A YU170475A YU170475A YU 170475 A YU170475 A YU 170475A YU 01704/75 A YU01704/75 A YU 01704/75A YU 170475 A YU170475 A YU 170475A YU 170475 A YU170475 A YU 170475A
Authority
YU
Yugoslavia
Prior art keywords
galenic formulations
preparing
preparing galenic
formulations
galenic
Prior art date
Application number
YU01704/75A
Other languages
English (en)
Inventor
J Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of YU170475A publication Critical patent/YU170475A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
YU01704/75A 1974-07-05 1975-07-02 Process for preparing galenic formulations YU170475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (1)

Publication Number Publication Date
YU170475A true YU170475A (en) 1984-02-29

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01704/75A YU170475A (en) 1974-07-05 1975-07-02 Process for preparing galenic formulations

Country Status (14)

Country Link
JP (1) JPS5132724A (de)
AU (1) AU8280175A (de)
BE (1) BE831042A (de)
DE (1) DE2528516A1 (de)
ES (1) ES439113A1 (de)
FR (1) FR2276832A1 (de)
GB (1) GB1518683A (de)
HU (1) HU170215B (de)
IL (1) IL47634A (de)
NL (1) NL7507798A (de)
NZ (1) NZ178011A (de)
SE (1) SE7507414L (de)
YU (1) YU170475A (de)
ZA (1) ZA754304B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
FR2483235A1 (fr) * 1980-05-28 1981-12-04 Fabre Sa Pierre Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees
JPS59216825A (ja) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS6013720A (ja) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd 生理的活性剤の吸収促進剤
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (ja) * 1986-01-16 1995-04-19 久光製薬株式会社 外用ゲル製剤
JPH0735332B2 (ja) * 1986-02-25 1995-04-19 久光製薬株式会社 外用クリ−ム製剤
JPH0759519B2 (ja) * 1987-02-23 1995-06-28 株式会社資生堂 経皮吸収促進剤及びこれを含有する皮膚外用製剤
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3219096B2 (ja) * 1990-05-10 2001-10-15 ニコメド ファーマ エイエス ｎ―グリコフロール類及びｎ―エチレングリコール類を含有する医薬製剤
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
WO1995013048A1 (en) * 1993-11-12 1995-05-18 The Procter & Gamble Company Desquamation compositions containing salicylic acid and zwitterionic compounds
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
ES2379471T5 (es) † 1999-02-08 2015-05-26 Intarcia Therapeutics, Inc Vehículos viscosos biocompatibles de fase única no acuosos y procedimientos para su preparación
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP3421031A1 (de) 2006-08-09 2019-01-02 Intarcia Therapeutics, Inc Osmotisches verabreichungssystem mit kolbenanordnung
CN101715340A (zh) 2007-04-23 2010-05-26 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
KR101514342B1 (ko) 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 지방산계 이온 액체를 유효성분으로 하는 외용제 조성물
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
JP2012020991A (ja) 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820206B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3395369A1 (de) 2014-10-30 2018-10-31 Asahi Kasei Kabushiki Kaisha Verbesserer der transdermalen absorption und verbesserungshilfe der transdermalen absorption
KR102650751B1 (ko) 2015-06-03 2024-03-22 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug

Also Published As

Publication number Publication date
IL47634A0 (en) 1975-10-15
GB1518683A (en) 1978-07-19
BE831042A (fr) 1976-01-05
ES439113A1 (es) 1977-10-16
JPS5132724A (de) 1976-03-19
NZ178011A (en) 1978-07-28
SE7507414L (sv) 1976-01-07
ZA754304B (en) 1977-02-23
IL47634A (en) 1978-07-31
AU8280175A (en) 1977-01-13
FR2276832B1 (de) 1978-10-06
NL7507798A (nl) 1976-01-07
DE2528516A1 (de) 1976-01-22
FR2276832A1 (fr) 1976-01-30
HU170215B (de) 1977-04-28

Similar Documents

Publication Publication Date Title
YU170475A (en) Process for preparing galenic formulations
CS183829B2 (en) Process for preparing thienamycine
HU174074B (hu) Sposob poluchenija 4-polialkoksi-fenil-2-pirrolidona
JPS51125466A (en) Process for preparing graftcopolymer
HU171059B (hu) Sposob poluchenija piridazinil-benzimidazolov
HU171231B (hu) Sposob poluchenija iodo-polivinilpirrolidona
HU172615B (hu) Sposob poluchenija zamehhjonnykh fenil-alkil-aminov
CS187466B2 (en) Process for preparing 2-arylamino-2-imidazolines
CS191290B2 (en) Process for preparing aminoalkylphenyletheres
CS189730B2 (en) Process for preparing o-cyanazodyes
HU175380B (hu) Sposob poluchenija tiolkarbamatov
HU171837B (hu) Sposob poluchenija 14 al'fa-gidroksi-steroidov
CS193518B2 (en) Process for preparing moenomycine
IL44361A0 (en) Process for preparing 3-fluoro-cephalosporins
CS188259B2 (en) Process for preparing 2-anilinooxazoles
GB1486844A (en) Process for preparing 7beta-acylamino-7alpha-alkoxy-cephalosporins
CS188984B2 (en) Process for preparing 3-fluorbenzodiazepines
HU173847B (hu) Sposob poluchenija 6-metil-8 beta-izocianometil- ehrgolina
HU172658B (hu) Sposob poluchenija benzol-sul'fonil-karbamidov
HU172273B (hu) Sposob poluchenija 2-dejtero-3-ftor-dl-alanina
ZA75634B (en) Process for preparing injectionable compositions
JPS51125257A (en) Process for preparing 111deoxyy omegaapentanolprostagladine
CS189725B2 (en) Process for preparing substituted 1-phenoxy-3-p-hydroxyphenetylamino-2-hydroxyalkanoles
YU350674A (en) Process for preparing substituted s-alkyl-thiocarbamate
PH11648A (en) Process for preparing 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide